Literature DB >> 22745468

Role of interleukin 16 in multiple myeloma pathogenesis: a potential novel therapeutic target?

Anuj Mahindra, Kenneth C Anderson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22745468     DOI： 10.1093/jnci/djs274

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  5 in total

1.  Levels of interleukin-16 in peripheral blood of 52 patients with multiple myeloma and its clinical significance.

Authors:  Shi-Feng Long; Guo-An Chen; Mu-Shui Fang
Journal:  Int J Clin Exp Med       Date:  2015-12-15

2.  Cytokine (IL16) and tyrphostin actions on ovarian primordial follicle development.

Authors:  Amanda Feeney; Eric Nilsson; Michael K Skinner
Journal:  Reproduction       Date:  2014-06-26       Impact factor: 3.906

3.  Cancer Conditioned Medium Modulates Functional and Phenotypic Properties of Human Decidua Parietalis Mesenchymal Stem/Stromal Cells.

Authors:  E Bahattab; T Khatlani; F M Abomaray; S A Messaoudi; M H Abumaree
Journal:  Tissue Eng Regen Med       Date:  2019-11-01       Impact factor: 4.169

4.  HPV associated tumor cells control tumor microenvironment and leukocytosis in experimental models.

Authors:  Simone Cardozo Stone; Renata Ariza Marques Rossetti; Aleida Maria Lima; Ana Paula Lepique
Journal:  Immun Inflamm Dis       Date:  2014-05-18

5.  CircRNA circ_0000190 inhibits the progression of multiple myeloma through modulating miR-767-5p/MAPK4 pathway.

Authors:  Yashu Feng; Ling Zhang; Jieying Wu; Bijay Khadka; Zhigang Fang; Jiaming Gu; Baoqiang Tang; Ruozhi Xiao; Guangjin Pan; Jiajun Liu
Journal:  J Exp Clin Cancer Res       Date:  2019-02-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.